BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15840109)

  • 1. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
    Man I; Crombie IK; Dawe RS; Ibbotson SH; Ferguson J
    Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
    Jo SJ; Kwon HH; Choi MR; Youn JI
    Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.
    Black RJ; Gavin AT
    Br J Dermatol; 2006 Mar; 154(3):566-7. PubMed ID: 16445801
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultraviolet radiation and skin tumors].
    Zanetti R; Tumino R
    Med Lav; 1998; 89(2):142-8. PubMed ID: 9673104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
    Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
    J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of follow-up in narrowband ultraviolet B phototherapy.
    Diffey BL; Farr PM
    Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends and familial risks in squamous cell carcinoma of the skin.
    Hemminki K; Zhang H; Czene K
    Arch Dermatol; 2003 Jul; 139(7):885-9. PubMed ID: 12873883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
    J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with the development of skin cancer after liver transplantation.
    Mithoefer AB; Supran S; Freeman RB
    Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study.
    Han J; Colditz GA; Hunter DJ
    Int J Epidemiol; 2006 Dec; 35(6):1514-21. PubMed ID: 16943234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile phone use and the risk of skin cancer: a nationwide cohort study in Denmark.
    Poulsen AH; Friis S; Johansen C; Jensen A; Frei P; Kjaear SK; Dalton SO; Schüz J
    Am J Epidemiol; 2013 Jul; 178(2):190-7. PubMed ID: 23788669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.